Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet this
Print
Tatiana Gouin-Soboleva
employee of Sanofi, France
Poster(s):
(X) Structured Benefit-Risk for Enoxaparin Based on Real World Evidence Data in The Context of Its Label Extension for Treatment of Deep Vein Thrombosis and Pulmonary Embolism and Prevention of Its Recurrence in Active Cancer Patients
Friday, August 26, 2022
8:00 AM – 6:00 PM
CEST
